SUMMARY The haemodynamic effects of dopamine and isosorbide dinitrate alone and in combination were studied in 8 patients with chronic congestive cardiac failure. In 7 patients dopamine, 6,tg/kg per min, increased mean cardiac index from 2-0 to 3 0 1/min per m2 (P < 0.0005); mean stroke volume index from 20 to 27 ml/m2 (P < 0.0025), and mean left ventricular stroke work index from 14 to 20 g M/M2 (P < 0.0025). Mean left ventricular filling pressure did not change significantly. Isosorbide, 5 to 10 mg sublingually, reduced mean left ventricular filling pressure from 29 to 24 mmHg (P < 0.0005) and mean arterial pressure from 80 to 73 mmHg (P < 0 01), with no significant change in mean cardiac index, stroke volume index, or left ventricular stroke work index. When dopamine was reinfused after isosorbide administration mean cardiac index increased to 3 2 1/min per m2, stroke volume index to 31 mu/m2 (P < 0 05 vs dopamine alone), and left ventricular stroke work index to 23 g in/m2
Isosorbide dinitrate has been shown to be effective in reducing left ventricular filling pressure in patients with chronic congestive cardiac failure (Franciosa et al., 1974; Gray et al., 1975; Williams et al., 1977) though the improvement in other aspects of left ventricular function such as cardiac output appears to be modest.
This study was designed to examine the possibility that the combination of isosorbide and an inotropic agent may be a more effective form of therapy for patients requiring intensive treatmnent for severe congestive cardiac failure. Dopamine is a short acting inotropic drug which has been shown to be effective in the treatment of congestive cardiac failure (Beregovitch et al., 1974) and was, therefore, selected for the study.
Received for publication 11 October 1977. Patients and methods Eight patients with severe congestive cardiac failure were studied. Informed consent was obtained in all cases. Five patients were studied during an intensive treatment programme for severe intractable congestive cardiac failure. The remaining 3 patients were studied at the time of haemodynamic assessment for long-term isosorbide therapy for less severe, though disabling congestive cardiac failure. The aetiology was ischaemic heart disease in all but one patient who developed severe congestive cardiac failure in the early postoperative period after mitral valve replacement for mitral stenosis. This patient's left ventricular function was found to be normal at cardiac catheterisation before the operation. There was no evidence on clinical and echocardiographic grounds for prosthetic valve dysfunction. Isotope ventriculography indicated a severe reduction in 838 For convenience, changes in the pulmonary arterial end-diastolic pressure were taken to represent changes in left ventricular filling pressure (Bouchard et al., 1971; Mantleetal., 1976; Bussmann et al., 1977) .
Cardiac output was measured by the thermodilution technique (Ganz and Swan, 1972 ) using a Waters Cardiac Output Computer.
Control readings of heart rate, pulmonary arterial and systemic arterial pressures, and cardiac output were made. In addition, the frequency of ventricular ectopic beats when present was recorded during a 10-minute control period. Dopamine 6 ,tg/kg per min was then infused using a Harvard pump for 15 minutes at which time measurements were repeated. The infusion was then discontinued. After 15 minutes and further control measurements isosorbide 5 mg was administered sublingually. If no fall in left ventricular filling pressure was seen a further 5 mg was given. After 10 minutes measurements were repeated. Dopamine was then reinfused at the same dose rate for 15 minutes when measurements were repeated.
Although the study was completed without incident in 7 patients, in one (case 8) a pronounced sinus bradycardia (40 beats/minute with junctional escape beats) developed after 5 minutes of the second dopamine infusion. There was hypotension (systolic arterial pressure 60 mmHg) with diaphoresis associated with a profound fall in pulmonary arterial pressure (pulmonary arterial end-diastolic pressure < 10 mmHg). The bradycardia was promptly reversed by discontinuing the dopamine infusion and the administration of atropine 0-6 mg intravenously. Systemic arterial and pulmonary arterial pressures gradually returned to control within 45 minutes. Until this episode haemodynamic changes had followed a similar pattern to that observed in the other patients. There were no further complications. (Yang et al., 1972) where D = arterial end-diastolic pressure and S = peak systolic arterial pressure. Mean pulmonary arterial pressure (PA) was calculated in the same way. Mean cardiac index increased from 2-0 to 3 0 1/min/m2 (P < 010005), stroke volume index from 20 to 27 ml/m2 (P < 010025), and left ventricular stroke work index from 14 to 20 g Mi/M2 (P < 010025). Mean heart rate increased from 105 to 114 beats/minute (P < 0105), while mean pulmonary vascular resistance fell from 197 to 158 dynes s cm-5 (P < 0 025) and mean systemic vascular resistance from 1840 to 1328 dynes s cm-5 (P < 0101). Mean 4 3 2 pulmonary arterial pressure, pulmonary arterial end-diastolic pressure, and mean arterial pressure did not change significantly.
EFFECTS OF ISOSORBIDE
Mean pulmonary arterial end-diastolic pressure fell from 29 to 24 mmHg (P < 0 0005), mean arterial pressure from 80 to 73 mmHg (P < 0 01), and mean pulmonary arterial pressure from 37 to 32 mmHg (P < 0 01). There was no significant change in mean heart rate, cardiac index, stroke volume index, pulmonary vascular resistance, and left ventricular stroke work index. Mean vascular resistance fell from 1703 to 1554 dynes s cm-5 (P < 0 025).
COMBINED EFFECTS OF DOPAMINE AND ISOSORBIDE
There was a further increase in cardiac index in 5 patients and a slight fall in 2 compared with dopamine alone (Fig. 1) . Compared with dopamine alone stroke volume index increased from 27 to 31 ml/M2 (P < 0 05) and left ventricular stroke work index from 20 to 23 g M/M2 (P < 0-0125). Compared with dopamine alone mean pulmonary arterial end-diastolic pressure fell from 30 to 25 mm 841 Hg (P < 0 0005), and mean pulmonary arterial pressure from 40 to 34 mmHg (P < 0 0025). There was a further fall in pulmonary and systemic vascular resistance in all but one patient compared with dopamine alone, with no significant change in the mean. There was a small but significant fall in mean heart rate (mean 5 beats/minute, P < 0 01 dopamine alone). Mean values for mean arterial pressure did not change significantly.
Changes in mean values are illustrated in Fig. 2  and 3 Conversely isosorbide has been shown to reduce left ventricular filling pressure with little effect on cardiac output. Indeed, falls in cardiac output have been reported (Williams et al., 1977) possibly as a result of a fall in left ventricular filling pressure below optimal levels (Crexells et al., 1973) . Thus, though pulmonary venous congestion may be effectively relieved, an associated fall in cardiac output may compromise renal perfusion leading to further sodium and water retention in patients whose cardiac output is already reduced to a critical level.
group.bmj.com on June 25, 2017 -Published by http://heart.bmj.com/ Downloaded from 84ohn Stephens, Duncan Dymond, and Roworth Spurrell The principal actions of isosorbide on the peri-reported in patients with congestive cardiac failure pheral vasculature appear to be those of arteriolar treated with certain vasodilators; the fall in the left vasodilatation and venodilatation (Mason and ventricular filling pressure observed with vasodilator Braunwald, 1965) . The former reduces left ventri-therapy may be secondary to the reduction in cular afterload which Cohn (1973) argues is primarily afterload or because of dilatation of venous capaciresponsible for the haemodynamic improvement tance vessels. Dopamine is an inotropic drug which has a vasoconstrictor effect on certain peripheral vascular beds (Mark et al., 1970; Higgins et al., 1973) . In congestive cardiac failure these actions may have the undesirable effects of increasing left ventricular afterload and venous return; the former through arteriolar vasoconstriction and the latter through constriction of venous capacitance vessels. These effects may explain the failure of dopamine to reduce left ventricular filling pressure in congestive cardiac failure (Loeb et al., 1971) .
The hypothesis that combined therapy with an inotropic drug and a vasodilator will have a synergistic effect on the failing heart has been supported by the observation of this study. Thus the principal cardiac therapeutic effect of dopamine (increase in cardiac output and stroke volume) has been combined with that of isosorbide (reduction in left ventricular filling pressure) to achieve a more comprehensive improvement in left ventricular performance (Fig. 4) (Graham et al., 1968 (Come and Pitt, 1976) in patients with acute myocardial infarction. These authors suggested several possible mechanisms including vagal stimulation through pressure or length receptors in the right atrium or left ventricle. Since the bradycardia in our patient responded quickly to atropine, vagal discharge appears to be the final common pathway involved in its genesis.
It is possible that a lesser degree of vagal discharge occurred in all patients when dopamine was reinfused, which may explain the observed small fall in heart rate compared with the first infusion period.
Thus, though combined therapy with dopamine.
and isosorbide offers a promising new approach in the treatment of severe congestive cardiac failure it should be used with caution, perhaps more so in the patient whose left ventricular filling pressure falls in the lower range after isosorbide administration. 
